← FDA Drug Approvals (Drugs@FDA)

NYSTATIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PHARM ASSOC · Approved 2016-01-07

Drug application

FDA Application #

ANDA203621

Application type

Abbreviated New Drug Application (Generic)

Brand name

NYSTATIN

Generic name

NYSTATIN

Active ingredients

NYSTATIN

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

PHARM ASSOC

Manufacturer

Pharmaceutical Associates, Inc.

First approval

2016-01-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown